Search This Blog

The Components Of Vaccine Formulation

By Shawn Hunter


Prophylactic vaccines are very vital in prevention of many of the infectious diseases in the world. Currently, only three vaccine types are in use for vaccinating human beings. The first one is the live-attenuated vaccines which have a bacterium or a virus with pathogenicity of low grade compared to the real one. The next is the inactivated ones. This is achieved by use of chemicals or heat while the subunit vaccine formulation is produced from pathogen components.

The purpose of vaccinating people is to strengthen their immune system action. This way, it would be hard for infectious agents to cause disease in them. In realizing this, there is a need to enhance the action of vaccines through the additions of some components. These are termed as adjuvants and they function to increase the potency of the vaccines and ensure that their effect persists for longer duration of time.

Adjuvants also enhance the immune action of body antigens. This means that less vaccine shots will be needed and also the efficacy of vaccines will be enhanced. The children and elderly people gain a lot from use of these vaccine formulations.

In general, adjuvants are categorized into two. The first class is the called the vehicles. They include virosomes, liposomes, emulsions and mineral salts which make the antigens in the vaccine to increase the efficiency of body immune system. Also, they control storage and release of antigens so that the specificity of immune responses is increased.

The other class consists of stimulants of immune system. They include agonists, toll-like receptors and MPLs. They work to enhance the function of immune system and increase its responsiveness to antigens which do not belong to the body. They are known to affect the level at which cytokines are produced through activation of intracellular pathways of signaling, MHC molecules and co-stimulatory signals.

Some of the adjuvants which have accepted for use in human beings include MPLs, virus-like particles and virosomes of influenza which have immune-potentiating effects. A combination of MPLs and alum is also commonly used in some regions of the world.

Use of formulations which have immune-potentiating properties has increased the effectives of many of these vaccines in use in the present including those used for protection against cancer, influenza and hepatitis viruses. By the virtue of crucial role of T cells in regulation of immune responses, adjuvants which can enhance and modulate T lymphocytes in the cytotoxic class or cause an effect to dendritic cells by exploiting TLR are preferred. This is because they offer a more coherent approach in designing vaccines based on their ability to bring about the most efficient immune response.

A lot of studies have been conducted in relation to vaccine formulations. One thing that is evident in all the researches done is that there is need for vaccine producers to come up with better types of adjuvants. This was arrived at considering that there have been several cases of failure of vaccines. The elderly and people with defective immune system have been hardly hit. The information given above is important but addition of more can be essential as well.




About the Author:



0 comments:

Post a Comment